The assembly of lipoprotein(a) (Lp(a)) particles occurs via a two-step mechanism in which noncovalent interactions between apolipoprotein(a) (apo(a)) and the apolipoproteinB-100 component of low density lipoprotein precede the formation of a single disulfide bond. Although we have previously demonstrated that the rate constant for the covalent step of Lp(a) assembly can be enhanced by altering the conformational status of apo(a), the resultant rates of covalent Lp(a) particle formation measured in vitro are relatively slow. The large excess of Lp(a) (over apo(a)) observed in vivo can be accounted for by a preferential clearance of apo(a) over Lp(a) and/or a sufficiently high rate of covalent Lp(a) assembly. In the present study, we report that cultured human hepatoma cells secrete an oxidase activity that dramatically enhances the rate of covalent Lp(a) assembly. This activity is likely possessed by a protein because it is heat-sensitive and is retained in the concentrate following ultrafiltration through a 5 kDa cutoff filter. However, a small molecule cofactor for the activity is suggested by the observation that the activity is lost upon dialysis. Plots of Lp(a) assembly rate versus input apo(a) concentration gave rectangular hyperbolae; the reaction displayed an unusual dependence on the concentration of apoB-100, with increasing concentrations of apoB-100 resulting in slower rates of Lp(a) assembly at low concentrations of apo(a), an effect that was alleviated by higher apo(a) concentrations. Interestingly, V(max(app))/K(m(app)) ratios were insensitive to apoB-100 concentration, which is diagnostic of a ping-pong reaction mechanism. In this way, the putative Lp(a) oxidase may be functionally analogous to protein disulfide isomerase, which exhibits a similar mechanism during the catalysis of disulfide bond formation during protein folding, although we have ruled out a role for this enzyme in Lp(a) assembly.

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi060283tDOI Listing

Publication Analysis

Top Keywords

lpa assembly
28
covalent lpa
16
lpa
12
disulfide bond
12
assembly
8
bond formation
8
rate covalent
8
apoa
7
activity
5
catalysis covalent
4

Similar Publications

Lipoprotein (a): Underrecognized Risk with a Promising Future.

Rev Cardiovasc Med

November 2024

Department of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

Lipoprotein a (Lp(a)) is a lipid biomarker that binds cholesterol and bears independent cardiovascular risk. Strategies to lower the level of Lp(a) and mitigate such risk are important both for primary and secondary prevention. Currently there are no approved therapies targeting Lp(a) directly.

View Article and Find Full Text PDF
Article Synopsis
  • Streptococcus pneumoniae is a significant cause of meningitis in underdeveloped countries with low vaccination rates, and this study analyzed 83 suspected meningitis patients in Karachi to identify and sequence the bacteria.
  • Out of 83 samples, 33 showed signs of potential meningitis, with 20 confirmed cases of bacterial meningitis, resulting in five isolates of S. pneumoniae being identified, one of which exhibited resistance to multiple antibiotics.
  • The whole-genome sequencing of the resistant strain revealed critical genetic factors for antibiotic resistance and indicated a close relation to strains from Hungary and the USA, contributing to our understanding of the prevalence and characteristics of S. pneumoniae in Karachi.
View Article and Find Full Text PDF

Lysophosphatidic acid responsive photosensitive supramolecular organic frameworks for tumor imaging, drug loading, and photodynamic therapy.

Spectrochim Acta A Mol Biomol Spectrosc

April 2024

School of Pharmacy, Thyriod and Breast Surgery, Medical Imaging Key Laboratory of Sichuan Province, Affiliated Hospital of North Sichuan Medical College, North Sichuan Medical College, Sichuan 637100, China. Electronic address:

Supramolecular organic frameworks have been widely applied for biological detection and drug delivery. In this study, a supramolecular organic framework (SOF) is constructed through the self-assembly of a highly photosensitive triarylphosphine oxide guest molecule, OTPP-6-Methyl, with cucurbit [8] uril (CB [8]). The formation of the SOF gradually enhances the weak fluorescence of OTPP-6-Methyl owing to the restriction of the molecular folding motion.

View Article and Find Full Text PDF

Small interfering RNA (siRNA) represents a novel, fascinating therapeutic strategy that allows for selective reduction in the production of a specific protein through RNA interference. In the cardiovascular (CV) field, several siRNAs have been developed in the last decade. Inclisiran has been shown to significantly reduce low-density lipoprotein cholesterol (LDL-C) circulating levels with a reassuring safety profile, also in older patients, by hampering proprotein convertase subtilisin/kexin type 9 (PCSK9) production.

View Article and Find Full Text PDF

Lysophosphatidic acid (LPA) is a promising biomarker candidate to screen for ovarian cancer (OC) and potentially stratify and treat patients according to disease stage. LPA is known to target the actin-binding protein gelsolin which is a key regulator of actin filament assembly. Previous studies have shown that the phosphate headgroup of LPA alone is inadequate to bind to the short chain of amino acids in gelsolin known as the PIP-binding domain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!